Last reviewed · How we verify

NCT00573014: CSclearance

Cervical Spine Clearance in Obtunded Trauma Patients

Completed Last updated 30 August 2017
What this trial tests

trial testing Cervical Spine Clearance in Coma in 197 participants. Completed in 30 September 2008.

Timeline
1 October 2006
Primary endpoint
1 July 2008
30 September 2008

Quick facts

Lead sponsorMetroHealth Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment197
Start date1 October 2006
Primary completion1 July 2008
Estimated completion30 September 2008
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

MetroHealth Medical Center

Who can join

Eligibility, any sex, with Coma or Wounds and Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The optimal method of clearing the cervical spine in obtunded trauma patients is unclear. Computed tomography (CT) identifies most injuries but may miss ligamentous injuries. Magnetic resonance (MR) imaging has been widely used to exclude ligamentous injuries. We postulate that with the new generation of CT scanners, MR imaging is not needed to rule out significant injuries. Our protocol for clearing the cervical spine in obtunded trauma patients depends on CT alone. We are prospectively following these patients and performing a clinical examination when they are awake to show this is a safe approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coma

Currently open trials in the same condition.

Other MetroHealth Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00573014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing